Who Paid My Doc
Richard Greco
Plastic Surgery Savannah, GA Medical Doctor
NPI 1366441321 CMS profile 61976
5361 Reynolds St, Savannah, GA 31405
General payments
$10,995
Research payments
$26,983
Ownership & investment interest
$0
Research they led as principal investigator
$204,760
Through program year 2025, Richard Greco of Savannah, GA is reported in the CMS Open Payments database as having received $10,995 across 63 general payments and $26,983 in research payments paid to them. Separately, studies naming them as principal investigator received $204,760 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 93rd percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
13 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $124 | 5 | |
| 2025 | Research | $15,763 | 4 | |
| 2024 | General | $311 | 9 | |
| 2024 | Research | $2,029 | 2 | |
| 2023 | General | $106 | 2 | |
| 2022 | General | $409 | 7 | |
| 2022 | Research | $4,558 | 2 | |
| 2021 | General | $264 | 14 | |
| 2021 | Research | $587 | 1 | |
| 2020 | General | $6,617 | 8 | |
| 2020 | Research | $1,561 | 2 | |
| 2019 | General | $3,163 | 18 | |
| 2019 | Research | $2,485 | 1 |
Beside peers
- Richard Greco
- Plastic Surgery median
- Middle half of Plastic Surgery
- National median
In program year 2025, general payments to Richard Greco were reported at $124. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.
Show as a table
| Year | Richard Greco | Plastic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $3,163 | $371 | $122–$1,483 | $163 |
| 2020 | $6,617 | $158 | $52–$438 | $114 |
| 2021 | $264 | $249 | $87–$752 | $132 |
| 2022 | $409 | $274 | $102–$793 | $149 |
| 2023 | $106 | $299 | $113–$891 | $160 |
| 2024 | $311 | $361 | $124–$1,062 | $164 |
| 2025 | $124 | $379 | $138–$1,100 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 7 drugsPart D claims
288
Drug cost
$822
Branded share of claims
19.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 55 | $349 | |
| Cephalexin | Generic | 92 | $283 | |
| Clindamycin Hcl | Generic | 15 | $64 | |
| Ondansetron Hcl | Generic | 11 | $35 | |
| Famotidine | Generic | 60 | $35 | |
| Tramadol Hcl | Generic | 17 | $31 | |
| Diazepam | Generic | 38 | $25 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,638 Part D prescribers listed as Plastic and Reconstructive Surgery; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 64 billing codesPaid by Medicare
$39,063
Medicare patients
128
Services billed
312
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 70% | |
| Arthritis | 49% | |
| Cancer | 21% | |
| Diabetes | 19% | |
| Osteoporosis | 18% | |
| Ischemic heart disease | 16% | |
| Atrial fibrillation | 13% | |
| Chronic kidney disease | 11% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
75 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Plastic Surgery in Georgia
Practitioners in the same specialty and state, ranked by reported value.
All Plastic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Georgia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.